Interview with Jen Chen, General Manager, Genovate
Genovate was founded in 1995. It is a very interesting story: a mix of biotech, the history with American company Genelabs, government investments and also private investment through Chinachem. Can…
Address: 9F, 12, Sec. 2, Ren-Ai Rd.
Taipei, Taiwan 10060
R.O.C.
Tel: -23211094
Web: http://www.genovate-bio.com/CHINESE/index.htm
Biopharmaceuticals
Genovate Biotechnology Co., Ltd. (GBL), a fully integrated biopharmaceutical company located in Taiwan, pursues the following missions: 1) Establish and meet the US FDA’s standards for current Good Manufacturing Practice (cGMP) and manufacture high quality products; 2) Bring together leading-edge technologies and talented people domestically and from overseas for the research and development of new therapeutic agents; 3) Conduct clinical studies in accordance with International Conference on Harmonisation (ICH) Guideline for Good Clinical Practice (GCP).
Genovate was founded in 1995. It is a very interesting story: a mix of biotech, the history with American company Genelabs, government investments and also private investment through Chinachem. Can…
Carol Cheng, COO of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), the association gathering 28 Taiwan-based, R&D-driven biopharmaceutical companies, highlights the association’s eye-catching initiative to boost international collaboration between academia…
James Chen, founder and Chairman of the board of Vetco, the first Taiwan-based veterinary company to have successfully developed an innovative veterinary oncology product, documents the main specificities of Vetco’s…
Johnsee Lee, founder, CEO, and president of Personal Genomics and its sister company Quark Biosciences, provides insights into the company’s proprietary Optoelectronic Sequencing (OES) technology, which can perform whole genome…
Ben Chien, Chairman, President and CEO, of Foresee Pharmaceuticals, one of Taiwan’s most vibrant success stories, discusses how Foresee has achieved successful phase III results for its prostate cancer treatment,…
Dr. Hui-Ting Huang, President of Taiwan Adventist Hospital, discusses the challenges of long-term care and the role preventive medicine plays within this scope, while also providing insights on running one…
Dr. Tzu-Ling (Karen) Tseng, CEO of Bio Preventive Medicine Corporation in Taiwan, discusses the innovative technology of its patented biomarkers, the success of DNlite and company’s strategy to grow through…
C.Y. Cheng, chairman and president of Formosa Laboratories, shares exciting news about the establishment of a new drug development company, Formosa Pharmaceuticals. He explains how the know-how gained from running…
With 7,000 employees in 25 locations across 12 countries in the region, PAREXEL now has more than a third of its global staff in Asia Pacific (APAC). Albert Liou, Vice…
Chih-Yi Weng, chairlady and CEO of Charsire Biotechnology, one of Taiwan’s leading biotech companies focused on the development of botanical new drugs as well as topical and personal care products,…
Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s…
Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s…
Lee Po-Chang, director general of Taiwan’s National Health Insurance Administration (NHIA) details his main priorities to further strengthen the country’s widely acclaimed single-payer health system, which already stands as one…
See our Cookie Privacy Policy Here
